Alliance scholar awardS

The Alliance for Clinical Trials in Oncology and Brigham and Women’s Hospital welcome applications for the Alliance Scholar Awards each year.

Alliance Scholar Award applicants are oncology junior faculty at Alliance institutions within five (5) years of training (rank below Associate Professor), who have completed training in an oncology clinical specialty (e.g., medical, surgical, radiation, gynecologic, etc.). Applicant proposals are nominated by an Alliance Scientific Committee Chair and are closely tied to the research agenda of the Alliance. Potential applicants must work with the relevant Alliance Scientific Committee Chair prior to submission of an application to ensure endorsement of the relevant Alliance Scientific Committee and include a letter of support from the relevant Alliance Scientific Committee Chair with application materials.

Alliance Scholar Award recipients receive a two-year, non-renewable cancer research grant of $40,000 direct costs per year. Projects supported by other non-institutional funds are not eligible.

An independent scientific review committee, convened by the Alliance for Clinical Trials in Oncology, reviews endorsed applications. Successful applicants are notified prior to and acknowledged during the Plenary Session of the Alliance Fall Group Meeting.

To learn more about Alliance Scholar Awards, please e-mail

Award Recipients

Xiao X. Wei, MD, MAS
- Instructor of Medicine, Harvard Medical School | Dr. Emil "Tom" Frei III ASA Project
Title: "Impact of Immunotherapy Discontinuation on Health Economics in Patients with Advanced Urothelial Carcinoma in a Non-Inferiority Phase 3 Trial"
Neha Mehta-Shah, MD, MSCI
- Assistant Professor of Medicine, Washington University School of Medicine | ASA Project
Title: "Evaluating Minimal Residual Disease in Peripheral T-cell Lymphomas Being Treated for Curative Intent in A051902"